Northwestern Mutual Wealth Management’s Capricor Therapeutics CAPR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19	Closed	-$262	–	3691
2024 Q4	$262	Hold	19	–	–	﹤0.01%	3431
2024 Q3	$289	Hold	19	–	–	﹤0.01%	3403
2024 Q2	$91	Buy	+19	New	+$106	﹤0.01%	3396
2022 Q3	–	Sell	-500	Closed	-$2K	–	3137
2022 Q2	$2K	Hold	500	–	–	﹤0.01%	2901
2022 Q1	$2K	Hold	500	–	–	﹤0.01%	2903
2021 Q4	$1K	Hold	500	–	–	﹤0.01%	3006
2021 Q3	$2K	Hold	500	–	–	﹤0.01%	2831
2021 Q2	$3K	Hold	500	–	–	﹤0.01%	2736
2021 Q1	$2K	Hold	500	–	–	﹤0.01%	2587
2020 Q4	$2K	Sell	500 -3,500	-88%	-$15.2K	﹤0.01%	2515
2020 Q3	$21K	Buy	+4,000	New	+$23.3K	﹤0.01%	1777

Other funds holding CAPR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northwestern Mutual Wealth Management's CAPR Position: Q1 2025 in Review

Northwestern Mutual Wealth Management sold out of Capricor Therapeutics (CAPR) in Q1 2025, closing a stake of 19 shares — an estimated $262 sold.

Northwestern Mutual Wealth Management first reported a position in CAPR in Q3 2020 and held it in 11 quarters. The position peaked at $21K in Q3 2020. 120 funds tracked by Wall St. Rank hold CAPR as of Q1 2025.

Northwestern Mutual Wealth Management reported no remaining Capricor Therapeutics position as of Q1 2025 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 19 Capricor Therapeutics shares in Q1 2025, an estimated $262.
Northwestern Mutual Wealth Management first reported a position in Capricor Therapeutics in Q3 2020 and held it in 11 quarters.
Northwestern Mutual Wealth Management's Capricor Therapeutics position peaked at $21K in Q3 2020.
120 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.